National Pharmacy Health & Leadership Alliance Verify a MemberMember Login
NPHLANational Pharmacy Health & Leadership Alliance
Apply for Membership

03Aesthetics & LongevityWhat Changed TodayUpdated

What changed today in Aesthetics & Longevity: 1 trial update, 1 new study, 1 recall record

Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.

By NPHLA IntelligencePublished Last updated Automated from official records

The signal

NPHLA tracked 3 new official records on this desk today: 1 trial update, 1 new study, 1 recall record.

Why this matters

New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.

What changed

  1. New trial registered: Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia[1]
  2. New research in Chronic diseases and translational medicine: “GelMA-Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full-Thickness Skin Wound Healing”.[2]
  3. Recall: HAIFA SMOKED FISH Recalls Cold Smoked Sprats Due to Potential Health Risk — reason given: not stated (firm: not stated).[3]
  4. Also reported by Dermatology Times: “Case 2: Assessing Severity and Rapid Progression in Alopecia Areata”.[4]
  5. Also reported by Dermatology Times: “Alopecia Areata Patient-Reported Outcomes: Defining Treatment Success and Monitoring Response”.[5]
  6. Also reported by Healthcare Dive: “Bon Secours affiliate makes $5.7B bid for Surgery Partners”.[6]

Who this affects

  • Med spas
  • Medical directors
  • Prescribers
  • Practice owners & operators
  • Pharmacies

What to watch next

No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
  2. [2]
  3. [3]
  4. [4]
    Case 2: Assessing Severity and Rapid Progression in Alopecia Areata

    News reportingDermatology TimesIndustry coverage — headline and link only

  5. [5]
    Alopecia Areata Patient-Reported Outcomes: Defining Treatment Success and Monitoring Response

    News reportingDermatology TimesIndustry coverage — headline and link only

  6. [6]
    Bon Secours affiliate makes $5.7B bid for Surgery Partners

    News reportingHealthcare DiveIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.

Update timeline

  1. First published.
  2. Added 2 new official records.